News
Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results